Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | |
LEP methylation | 1.496 (0.979–2.287) | 0.063 | 1.584 (1.018–2.464) | 0.041 |
Age | 2.015 (1.362–2.981) | 0.000 | 1.802 (1.203–2.700) | 0.004 |
WBC | 1.933 (1.302–2.870) | 0.001 | 1.796 (1.209–2.668) | 0.004 |
Cytogenetic risks | 1.525 (1.173–1.982) | 0.002 | 1.388 (1.050–1.834) | 0.021 |
NPM1 mutations | 0.646 (0.310–1.346) | 0.243 |  |  |
FLT3-ITD mutations | 0.905 (0.416–1.967) | 0.801 |  |  |
C-KIT mutations | 0.757 (0.239–2.402) | 0.636 |  |  |
N/K-RAS mutations | 0.944 (0.470–1.895) | 0.871 |  |  |
DNMT3A mutations | 1.420 (0.653–3.088) | 0.377 |  |  |
U2AF1 mutations | 2.293 (0.709–7.413) | 0.166 |  |  |
IDH1/2 mutations | 0.722 (0.226–2.309) | 0.583 |  |  |
SRSF2 mutations | 1.892 (0.685–5.222) | 0.218 |  |  |
SETBP1 mutations | 0.576 (0.080–4.152) | 0.584 |  |  |